Genprex Inc GNPX

NAS: GNPX | ISIN: US3724461047   30/04/2025
0,290 USD (+3,57%)
(+3,57%)   30/04/2025
Grafiek Genprex Inc Grafiek Genprex Inc

Genprex Inc in het nieuws

30 april 2025 · Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting · Persbericht

29 april 2025 · Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting · Persbericht

28 april 2025 · Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma · Persbericht

24 april 2025 · Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting · Persbericht

22 april 2025 · Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings · Persbericht

26 maart 2025 · Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting · Persbericht

25 maart 2025 · Genprex Collaborators Selected to Present Positive Preclinical Data on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions · Persbericht

4 maart 2025 · Genprex to Participate at BIO Europe Spring 2025 · Persbericht

9 september 2024 · Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics · Persbericht

4 september 2024 · Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes · Persbericht

Profiel Genprex Inc

Fabricage van farmaceutische preparaten
Farmaceutica
Gezondheidstechnologie
Productie

Website: www.genprex.com

Hoofdzetel: Austin, Texas vlag Verenigde Staten

CEO: J. Rodney Varner

Werknemers: 26

Mijn selecties